CROI 2017 Program and Information

Program and Agenda

291 ALTERED STABILITY OF HIV-INFECTEDMEMORY CELLS FOLLOWING VERY EARLY ART Louise Leyre 1 , Jintanat Ananworanich 2 , Claire Vandergeeten 3 , Eugene Kroon 4 , Nitiya Chomchey 5 , Siriwat Akapirat 6 , Merlin L. Robb 2 , Nittaya Phanuphak 7 , Nicolas Chomont 8 , for the RV254/SEARCH010 and RV304 Study Groups 1 Cntr de Rsr du Cntr Hosp de l’Univ de Montréal, Montréal, Québec, Canada 2 US Military HIV Rsr Prog, Silver Spring, MD, USA, 3 Vaccine and Gene Therapy Inst, Port St Lucie, FL, USA, 4 SEARCH, The Thai Red Cross AIDS Rsr Cntr, Bangkok, Thailand, 5 Armed Forces Rsr Inst of Med Scis, Bangkok, Thailand, 6 Thai Red Cross AIDS Rsr Cntr, Bangkok, Thailand, 7 Univ de Montréal, Montreal, QC, Canada 306 MURINEMODEL TO PREDICT VIRAL REBOUND INHIV+ ALLOTRANSPLANTED SUBJECTS Maria Salgado 1 , Mi Kwon 2 , Cristina Galvez Celada 1 , Monique Nijhuis 3 , Cristina Vilaplana 4 , Alessandra Bandera 5 , Annemarie Wensing 3 , Jose Luis Diez 2 , Javier Martinez-Picado 1 , for the IciStem Consortium 1 IrsiCaixa AIDS Rsr Inst, Badalona, Spain, 2 Gregorio Maranon Hosp, Madrid, Spain, 3 Univ Med Cntr Utrecht, Utrecht, Netherlands, 4 Inst for Hlth Sci Rsr Germans Trias i Pujol, Badalona, Spain, 5 Univ of Milano–Bicocca, Milan, Italy 307 ROLE OF HIGH-MOBILITY GROUP A1 (HMGA1) GENE EXPRESSION IN REACTIVATION OF LATENT HIV Hosiana Abewe 1 , Amey Mukim 2 , Savitha Deshmukh 2 , Celsa A. Spina 2 , Douglas D. Richman 1 , Nadejda Beliakova-Bethell 2 1 Univ of California San Diego, La Jolla, CA, USA, 2 VA San Diego Hlthcare System, San Diego, CA, USA 308 INVESTIGATING THEMECHANISMS OF HIV-1 LATENCY BY HIGH- RESOLUTIONMICROSCOPY Luca Sardo 1 , Angel Lin 1 , Svetlana Khakhina 1 , Lucas Beckman 1 , Weam Elbezanti 1 , Tara Jaison 1 , Harshad D. Vishwasrao 2 , Hari Shroff 2 , Christopher J. Janetopoulos 1 , Zachary A. Klase 1 1 Univ of the Scis, Philadelphia, PA, USA, 3 NIH, Bethesda, MD, USA 309 CURRENT LATENCY REVERSING AGENTS REACTIVATE A SMALL FRACTION OF LATENT PROVIRUSES Anthony R. Cillo 1 , Joshua C. Cyktor 1 , Michele Sobolewski 1 , Taylor Buckley 1 , Joseph Hesselgesser 2 , Tomas Cihlar 2 , Romas Geleziunas 2 , Jeffrey Murry 2 , John W. Mellors 1 1 Univ of Pittsburgh, Pittsburgh, PA, USA, 2 Gilead Scis, Foster City, CA, USA 310 LATENCY REVERSAL USING SPECIFIC ANTIGENS INCLUDING THOSE OF HIV-1 Thomas Vollbrecht 1 , Aaron Angerstein 2 , John Guatelli 2 1 Veterans Med Rsr Fndn, San Diego, CA, USA, 2 Univ of California San Diego, La Jolla, CA, USA 311 IDENTIFICATION OF LRAS ACTIVE IN DIVERSE PRIMARY T-CELL MODELS OF HIV LATENCY Richard Barnard 1 , Jenny L. Anderson 2 , Daria Hazuda 1 , Sharon R. Lewin 2 , Laura J. Martins 3 , Mauricio Montano 4 , Vicente Planelles 3 , Celsa A. Spina 5 , for the CARE Collaboratory 1 Merck & Co, Inc, West Point, PA, USA, 2 The Univ of Melbourne, Melbourne, Australia, 3 Univ of Utah, Salt Lake City, UT, USA, 4 Univ of California San Francisco, San Francisco, CA, USA, 5 VA San Diego Hlthcare System, San Diego, CA, USA Poster P-E6 LATENCY REVERSAL Poster Hall - 4 EF 2:30 PM - 4:00 PM

Poster Sessions • Wednesday

CROI 2017 128